Loading stock data…
NUTX
$139.57+20.37 (+17.09%)
Market ClosedLast close May 1
Nutex Health Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Nutex Health Inc. in the Healthcare sector is trading at $139.57. The stock is currently 28% below its 52-week high of $193.07, remaining 19.8% above its 200-day moving average. Technical signals show overbought RSI of 77 and bullish MACD crossover, explaining why NUTX maintains its current momentum and trend strength. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 77) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$139.57
Potential Upside
115.6%
Whystock Fair Value$300.90
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Mean target$221.67+58.8%
Range$150.00 – $300.00
Fundamentals
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network o...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$766.53M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
10.34
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.02
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
21.49%
Volume
Today's trading volume
398,900
Recent News
Nutex Health Q1 Earnings Call Highlights
Nutex Health (NASDAQ:NUTX) reported first-quarter 2026 revenue growth and a sharp increase in net income, while management emphasized ongoing investments in operational infrastructure, a growing pipeline of new facilities, and a shift toward internally funding certain de novo hospital developments.
Nutex Health, Inc. Q1 2026 Earnings Call Summary
Moby summary of Nutex Health, Inc.'s Q1 2026 earnings call
Nutex Health Annual Meeting: Shareholders Elect Directors, Approve Say-on-Pay and Auditor Ratification
Nutex Health (NASDAQ:NUTX) held its annual meeting of stockholders virtually on April 23, 2026, with Chief Executive Officer and Chairman Dr. Thomas T. Vo presiding. The meeting focused on three voting proposals: the election of seven directors, a non-binding advisory vote on executive compensation,
US Market's Hidden Treasures 3 Promising Small Caps With Strong Potential
The United States market has seen a notable uptick, rising 1.9% over the last week and an impressive 24% over the past year, with earnings projected to grow by 15% annually. In this dynamic environment, identifying promising small-cap stocks can offer unique opportunities for investors seeking growth potential beyond the well-trodden paths of larger companies.
Exploring Three Undervalued Small Caps With Insider Action Across Regions
The United States market has experienced a positive trend, with a 1.9% increase over the last week and a substantial 24% rise over the past year, while earnings are projected to grow by 15% annually in the coming years. In such an environment, identifying stocks that are potentially undervalued can be appealing to investors seeking opportunities for growth, especially when there is notable insider activity suggesting confidence in these companies' prospects.